AI and Healthcare: What Penn Medicine Wants to Do

3min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

Gillis: I like to break it down into, you know, more chatbots, predictive analytics, elimination of repetitive human functions. An example of what's on my mind is screening colonoscopy. Right now it's a very blood instrument,. You hit age 40 you're supposed to get a call asking me. Gills: Wouldn't it be great if at age 30, we could gene sequence everybody? And so I'm AI for predictive analytics is where I'll mostly excited about.

Today, we're thrilled to introduce you to Kevin Mahoney, an exceptional individual with an extensive background in healthcare leadership. Kevin has been an integral part of Penn Medicine since 1996, holding various leadership positions within the health system and the Perelman School of Medicine. His transformative projects have elevated Penn Medicine's clinical care, teaching, and research missions.

Before joining Penn Medicine, Kevin displayed exceptional leadership as the vice president for Johnson and Higgins, focusing on risk transfer and alternative risk management strategies. He also held administrative roles at Bryn Mawr Hospital and Episcopal Hospital.

Kevin's insights on health equity, access to quality care, and social justice have been featured in prestigious publications like the New England Journal of Medicine, JAMA, and The Philadelphia Inquirer. Modern Healthcare recognized his influence by including him in its list of the 100 most influential people in healthcare in 2022.

In this episode we talk about Kevin’s journey to healthcare leadership, the increasing costs of care, how founders can partner with Penn Medicine, and insights on the consolidation in healthcare.